Somerset Trust Co Has $3.33 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Somerset Trust Co raised its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,573 shares of the healthcare conglomerate’s stock after purchasing an additional 310 shares during the period. Somerset Trust Co’s holdings in UnitedHealth Group were worth $3,325,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of UNH. Bristol Gate Capital Partners Inc. grew its holdings in shares of UnitedHealth Group by 7.2% during the 2nd quarter. Bristol Gate Capital Partners Inc. now owns 184,925 shares of the healthcare conglomerate’s stock valued at $94,175,000 after purchasing an additional 12,372 shares during the last quarter. Intech Investment Management LLC increased its holdings in shares of UnitedHealth Group by 1.0% during the second quarter. Intech Investment Management LLC now owns 337,254 shares of the healthcare conglomerate’s stock worth $171,750,000 after buying an additional 3,348 shares in the last quarter. Brighton Jones LLC grew its position in UnitedHealth Group by 47.4% during the 2nd quarter. Brighton Jones LLC now owns 26,302 shares of the healthcare conglomerate’s stock worth $13,394,000 after acquiring an additional 8,458 shares during the last quarter. Ieq Capital LLC raised its position in UnitedHealth Group by 4.6% in the second quarter. Ieq Capital LLC now owns 62,584 shares of the healthcare conglomerate’s stock valued at $31,872,000 after purchasing an additional 2,775 shares during the last quarter. Finally, Benjamin F. Edwards & Company Inc. increased its stake in shares of UnitedHealth Group by 4.8% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 39,031 shares of the healthcare conglomerate’s stock valued at $19,877,000 after buying an additional 1,770 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 0.1 %

UNH opened at $510.03 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The company’s 50-day moving average is $551.50 and its 200 day moving average is $562.62. The firm has a market capitalization of $469.37 billion, a PE ratio of 33.23, a P/E/G ratio of 1.42 and a beta of 0.62. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. UnitedHealth Group’s revenue was up 6.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $5.83 earnings per share. As a group, research analysts predict that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.65%. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on UNH shares. Piper Sandler decreased their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. Royal Bank of Canada lowered their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research report on Wednesday, October 16th. Oppenheimer increased their price target on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Morgan Stanley reduced their target price on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. Finally, HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective for the company in a research report on Friday, January 10th. Two equities research analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Buy” and an average target price of $627.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.